Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.
A subject-specific framework for in vivo myeloarchitectonic analysis using high resolution quantitative MRI.
Cover Images.
1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis.
Effect of a neurohospitalist service on outcomes at an academic medical center.
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
Naturally Occurring Antibodies as Therapeutics for Neurologic Disease : Can Human Monoclonal IgMs Replace the Limited Resource IVIG?
Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1.
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis.
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
Clinically isolated syndrome manifested as acute vestibular syndrome: Bedside neuro-otological examination and suppression of transient evoked otoacoustic emissions in the differential diagnosis.
A role for human brain pericytes in neuroinflammation.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Subcutaneous IgG in neurologic diseases.
Tropical myelopathies.
Another promising oral agent for multiple sclerosis.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
The ethics of placebo controlled clinical trials in NMO - A balance of risks.
Advances of Molecular Imaging for Monitoring the Anatomical and Functional Architecture of the Olfactory System.
Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy.
Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature.
MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.
Pages
« first
‹ previous
…
430
431
432
433
434
435
436
437
438
…
next ›
last »